Mock, A., Plath, M., Moratin, J., Tapken, M. J., Jäger, D., Krauß, J., . . . Plath, K. (2021). EGFR and PI3K pathway activities might guide drug repurposing in HPV-negative head and neck cancers. Frontiers in oncology, 11, . https://doi.org/10.3389/fonc.2021.678966
Chicago-Zitierstil (17. Ausg.)Mock, Andreas, Michaela Plath, Julius Moratin, Maria Johanna Tapken, Dirk Jäger, Jürgen Krauß, Stefan Fröhling, Jochen Heß, und Karim Plath. "EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-negative Head and Neck Cancers." Frontiers in Oncology 11 (2021). https://doi.org/10.3389/fonc.2021.678966.
MLA-Zitierstil (9. Ausg.)Mock, Andreas, et al. "EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-negative Head and Neck Cancers." Frontiers in Oncology, vol. 11, 2021, https://doi.org/10.3389/fonc.2021.678966.